Financial intelligence for Asia's healthcare markets
Remember me:

News articles    

Thailand’s hospitals will suffer a short-term cut in their profits by 4-5% because the country’s Social Security Office cutting remuneration rates for treatments
WuXi Biologics, a Hong Kong-listed biologics company based in Wuxi, eastern China, and Bayer, the German multinational pharmaceutical and life sciences company have jointly announced an acquisition agreement.
The Asia-Pacific healthtech ecosystem closed at $5 billion invested, across 340 deals, in 2019 Galen Growth has revealed.
Manila-based Ayala Healthcare Holdings has acquired Healthway Philippines, via its wholly-owned subsidiary AC Health.
Teledentistry company SmileDirectClub, a medtech platform for direct-to-consumer teeth straightening, is extending its operations into Hong Kong, opening two shops in the territory.
Châtillon-France consumer healthcare company HRA Pharma today announced a joint venture with Profex, a specialty pharmaceutical and personal care company focusing on skin health and medical aesthetics in China.
Singapore-based HC Surgical Specialists has signed a three-year agreement with The Prestige Hospital Co in Cambodia, to operate an endoscopy centre.
AXA has launched the ‘Mind Health’ programme in Hong Kong, which the insurer claims is the territory’s first employee mental healthcare scheme.
There was $226 million worth of healthtech investments in Southeast Asia in 2019, with Singapore and Indonesia accounting for about 93% of the total.
ISEC Healthcare, via its Malaysian unit ISEC, has entered into a conditional sale and purchase agreement to acquire Indah Specialist Eye Centre in Malaysia for $12.2 million.

Subscribe to our news RSS feed Get the RSS for HealthInvestor Asia




The IPO market in Hong Kong is hotting up again and it looks as though 2019 is going to be as busy with biotech company floats as last year was.



HealthInvestor Asia twitter feed


HealthInvestor UK